Affinity Asset Advisors’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-250,000
Closed -$2.75M 108
2025
Q1
$2.75M Buy
+250,000
New +$2.75M 0.26% 45